Sun Pharma's Dadra facility receives OAI status from US FDA

The US FDA conducted an inspection at Sun Pharmaceutical Industries Limited's Dadra facility from December 4, 2023 to December 15, 2023. US FDA has subsequently determined that the inspection classification status of this facility as Official Action Indicated (OAI).

Shares of Sun Pharmaceutical Industries Limited was last trading in BSE at Rs. 1604.00 as compared to the previous close of Rs. 1602.80. The total number of shares traded during the day was 97627 in over 6052 trades.

The stock hit an intraday high of Rs. 1609.20 and intraday low of 1583.75. The net turnover during the day was Rs. 155509919.00.

Source : Equity Bulls

Keywords

SunPharmaceuticalIndustries INE044A01036 DadraFacility USFDA OAI